Sucampo Pharmaceuticals, Inc. logo

Sucampo Pharmaceuticals, Inc. Employee Directory

Pharmaceutical ManufacturingMaryland, United States11-50 Employees

Sucampo Pharmaceuticals, Inc. is a small-to-mid-sized pharmaceutical company focused on developing and commercializing medicines that address major unmet medical needs of patients worldwide. The company markets AMITIZA as its lead product and RESCULA, and it maintains a global presence with headquarters in Rockville, Maryland, and operations in Japan, Switzerland, and the United Kingdom. AMITIZA is a registered trademark of Sucampo AG, reflecting the corporate structure of the group. The company’s products are aimed at patients with unmet medical needs across global markets. In March 2024, Takeda Pharmaceuticals terminated its collaboration and license agreement related to AMITIZA, and Takeda no longer sells or markets the product.

Find Sucampo Pharmaceuticals, Inc. employees' phone numbers or email addresses

Sucampo Pharmaceuticals, Inc. Global Highlights

Location
Employees

North America
46

Minus sign iconPlus sign icon
  • United States Of America
    45
  • Costa Rica
    1

Asia
3

Minus sign iconPlus sign icon
  • Japan
    3

Europe
3

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    1
  • France
    1
  • Italy
    1

South America
1

Minus sign iconPlus sign icon
  • Colombia
    1

Sucampo Pharmaceuticals, Inc.'s Leadership

  • Chief Financial Officer at Sucampo Pharmaceuticals, Inc.
    A. S.
    Chief Financial Officer
  • Chief Financial Officer at Sucampo Pharmaceuticals, Inc.
    P. P.
    Chief Financial Officer
  • Senior Vice President Of Research And Development at Sucampo Pharmaceuticals, Inc.
    G. D.
    Senior Vice President Of Research And Development
  • Vice President, Clinical Development at Sucampo Pharmaceuticals, Inc.
    T. J.
    Vice President, Clinical Development
  • Vice President, Clinical Development at Sucampo Pharmaceuticals, Inc.
    T. L.
    Vice President, Clinical Development
  • Senior Vice President Business Development And Licensing at Sucampo Pharmaceuticals, Inc.
    W. B.
    Senior Vice President Business Development And Licensing
  • Cmc Director at Sucampo Pharmaceuticals, Inc.
    R. H.
    Cmc Director
  • Director at Sucampo Pharmaceuticals, Inc.
    B. M.
    Director

Sucampo Pharmaceuticals, Inc. Employee Metrics

100%
50%
0%
2026
2025
  • Administrative
  • Human Resources
  • Accounting
  • Business
  • Community & Social Services
  • Other
  • Analytics

Contact profiles from Sucampo Pharmaceuticals, Inc.

Name
Title
Contact
Location
Last Update
  • Chief Financial Officer at Sucampo Pharmaceuticals, Inc.
    A. S.
    Chief Financial Officer
    Oct 07, 2023
  • Chief Financial Officer at Sucampo Pharmaceuticals, Inc.
    P. P.
    Chief Financial Officer
    Oct 23, 2024
  • Senior Vice President Of Research And Development at Sucampo Pharmaceuticals, Inc.
    G. D.
    Senior Vice President Of Research And Development
    Jul 19, 2022
  • Vice President, Clinical Development at Sucampo Pharmaceuticals, Inc.
    T. J.
    Vice President, Clinical Development
    Sep 18, 2023
  • Vice President, Clinical Development at Sucampo Pharmaceuticals, Inc.
    T. L.
    Vice President, Clinical Development
  • Senior Vice President Business Development And Licensing at Sucampo Pharmaceuticals, Inc.
    W. B.
    Senior Vice President Business Development And Licensing
    Oct 18, 2024
  • Cmc Director at Sucampo Pharmaceuticals, Inc.
    R. H.
    Cmc Director
    Japan
    Aug 29, 2026
  • Director at Sucampo Pharmaceuticals, Inc.
    B. M.
    Director
    Oct 23, 2024
  • Associate Medical Director, Global Pharmacovigilance at Sucampo Pharmaceuticals, Inc.
    Y. Z.
    Associate Medical Director, Global Pharmacovigilance
    Oct 21, 2024
  • Senior Contracts Manager at Sucampo Pharmaceuticals, Inc.
    D. G.
    Senior Contracts Manager
    Aug 30, 2026

Frequently Asked Questions

What is Sucampo Pharmaceuticals, Inc. known for?

Minus sign iconPlus sign icon
Sucampo Pharmaceuticals, Inc. was founded in 1996 and operates in the Pharmaceutical Manufacturing industry. You can contact Sucampo Pharmaceuticals, Inc.'s main corporate office by phone at . Explore Sucampo Pharmaceuticals, Inc.'s company overview page for more information.

What is Sucampo Pharmaceuticals, Inc.'s most common email format?

Minus sign iconPlus sign icon
Sucampo Pharmaceuticals, Inc. employees' email format typically follows the pattern of FLast@sucampo.com. Trying to find reliable and up-to-date employee contact data? Find more Sucampo Pharmaceuticals, Inc. email formats with LeadIQ.

How many employees does Sucampo Pharmaceuticals, Inc. have currently?

Minus sign iconPlus sign icon
Sucampo Pharmaceuticals, Inc. has approximately 37 employees as of August 2026. These team members are located across 4 continents, including North America, Asia and Europe.

Who are Sucampo Pharmaceuticals, Inc.'s key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Sucampo Pharmaceuticals, Inc.'s key employees include:

  • Chief Financial Officer: A. S.
  • Chief Financial Officer: P. P.
  • Senior Vice President Of Research And Development: G. D.
  • Vice President, Clinical Development: T. J.
  • Vice President, Clinical Development: T. L.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.